CTS Viral Production Cells from Thermo Fisher Scientific

Description

  • Core component of the CTS™ LV-MAX™ Lentiviral Production System to produce maximal lentiviral titers
  • Cells allow high density, serum-free suspension culture with minimal cell clumping in CTS™ LV-MAX™ Production Medium
  • Specifically validated for lentiviral vector production for the purpose of cell and gene therapy applications, but may be suitable for the production of other viral vectors where the absence of SV40 large T antigen in HEK293 cells is desired
  • cGMP-banked cells have gone through a documented validation process to help ensure that they can be transfected with multiple plasmids and that viable viral particles can be produced
  • Fully-documented cGMP-banked cell line (HEK293F-derived) with detailed cell line lineage history
  • Extensive quality testing based on the US FDA and European Medicines Agency (EMA) guidances for therapeutic use
  • Flexible licensing options without royalties